A smart approach to enable preclinical studies in pharmaceutical industry: PLGA-based extended release formulation platform for subcutaneous applications-Reference-Cited by-同舟云学术

A smart approach to enable preclinical studies in pharmaceutical industry: PLGA-based extended release formulation platform for subcutaneous applications

Published:2020-03-20 Issue:4 Volume:46 Page:635-645
ISSN:0363-9045
Container-title:Drug Development and Industrial Pharmacy
language:en
Short-container-title:Drug Development and Industrial Pharmacy

Author:

Strack Patrick¹²,Külzer Raimund¹,Sommer Florian¹,Bretschneider Tom¹,Merkel Olivia M.²,Grube Achim¹

Affiliation:

1. Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany;

2. Ludwig-Maximilians Universität München, München, Germany

Publisher

Informa UK Limited

Subject

Organic Chemistry,Drug Discovery,Pharmaceutical Science,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/03639045.2020.1742146

Reference34 articles.

1. Success in translational research: lessons from the development of bortezomib

2. Development of ALZET® osmotic pump compatible solvent compositions to solubilize poorly soluble compounds for preclinical studies

3. Drug Delivery: Enabling Technology for Drug Discovery and Development. iPRECIO® Micro Infusion Pump: Programmable, Refillable, and Implantable

4. Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modeling the Microenvironment-Dependent Degradation of Drug-Loaded Polylactic-co-glycolic Microparticles;Industrial & Engineering Chemistry Research;2021-07-07

2. Buprenorphine loaded PLGA microparticles: Characterization of a sustained-release formulation;Journal of Drug Delivery Science and Technology;2021-06